Melexis NV's next confirmed earnings release is scheduled for February 3, 2027.
| Earnings Date | 2/3/2027 |
As of September 30, 2026, Melexis NV has 39.38M shares outstanding.
| Shares Outstanding | 39.38M |
As of September 30, 2026, Melexis NV maintains a current ratio of 5.79, meaning it holds 5.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.79 |
| Quick Ratio | 0.40 |
| Debt / Equity | 51.37 |
| Debt / EBITDA | 1.22 |
These figures cover the twelve months ended September 30, 2026. The company generates approximately 487,083.63 in revenue per employee across its workforce of 1,995.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 487,083.63 |
| Employee Count | 1,995.00 |
Over the twelve months ended September 30, 2026, Melexis NV recorded 26.81M in income tax expense. That works out to an effective tax rate of 18.00, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 148.96M, leaving 122.15M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 26.81M |
| Effective Tax Rate | 18.00 |
As of the close on October 22, 2026, Melexis NV's stock has declined approximately 16.88% over the past 52 weeks.
| 52-Week Price Change | -16.88% |
Over the twelve months ended September 30, 2026, Melexis NV generated 971.73M in revenue and converted that into 122.15M in net income, yielding earnings per share of 3.03. EBITDA reached 221.92M, while operating income came in at 163.80M.
| Revenue | 971.73M |
| Gross Profit | 387.55M |
| Operating Income | 163.80M |
| Pretax Income | 148.96M |
| Net Income | 122.15M |
| EBITDA | 221.92M |
| EBIT | 163.80M |
| Earnings Per Share (EPS) | 3.03 |
As of September 30, 2026, Melexis NV holds 42.37M in cash and equivalents against 270.49M in total debt, resulting in a net debt position of 218.74M. Total book value stands at 526.54M, with working capital of 502.63M providing operational flexibility.
| Cash & Cash Equivalents | 42.37M |
| Total Debt | 270.49M |
| Net Debt | 218.74M |
| Equity (Book Value) | 526.54M |
| Book Value Per Share | 13.37 |
| Working Capital | 502.63M |
Melexis NV produced 302.96M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -39.20M in capital expenditures, free cash flow totaled 263.75M - equivalent to 6.53 per share.
| Operating Cash Flow | 302.96M |
| Capital Expenditures | -39.20M |
| Free Cash Flow | 263.75M |
| FCF Per Share | 6.53 |
Over the twelve months ended September 30, 2026, Melexis NV posted a gross margin of 39.88, reflecting its pricing power and cost economics. The operating margin of 16.86 and net profit margin of 12.57 provide insight into operational efficiency.
| Gross Margin | 39.88 |
| Operating Margin | 16.86 |
| Pretax Margin | 15.33 |
| Profit Margin | 12.57 |
| EBITDA Margin | 22.84 |
Over the twelve months ended September 30, 2026, Melexis NV paid dividends of 4.11 per share. The dividend payout ratio of 135.78 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.
| Dividend Per Share | 4.11 |
| Payout Ratio | 135.78 |
Already premium?